APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival.

Authors :: Planelles L
Castillo-Gutiérrez S
Medema JP
Morales-Luque A
Merle-Béral H
Hahne M
Source :: Haematologica [Haematologica] 2007 Sep; Vol. 92 (9), pp. 1284-5.
Publication Year :: 2007
Abstract: APRIL (a proliferation-inducing ligand) and BLyS (B lymphocyte stimulator) expression have been reported in chronic lymphocytic leukemia (CLL) cells. We examined APRIL and BLyS serum levels in CLL patients and evaluated the prognostic significance of APRIL expression on survival.

Subjects :: Adolescent
Adult
Aged
Aged, 80 and over
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell mortality
Male
Middle Aged
Polymerase Chain Reaction
Prognosis
Retrospective Studies
Survival Rate
Leukemia, Lymphocytic, Chronic, B-Cell blood
Receptors, Tumor Necrosis Factor blood
Tumor Necrosis Factor Ligand Superfamily Member 13 blood

Full Text Access

Tools